Kamada (KMDA) FCF Payout Ratio Growth (3y) (2016 - 2026)
Kamada (KMDA) FCF Payout Ratio Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | -65.59% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 4.33% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.53% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn | -50.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50.94% |
| Mar 31, 2026 | 71.98% |
| Sep 30, 2025 | 5.35% |
| Jun 30, 2025 | -33.67% |
| Mar 31, 2025 | 179.04% |
| Dec 31, 2024 | 26.14% |
| Sep 30, 2024 | 26.70% |
| Jun 30, 2024 | 27.95% |
| Dec 31, 2023 | -22.43% |
| Sep 30, 2023 | 13.37% |
| Jun 30, 2023 | 15.84% |
| Dec 31, 2022 | 178.77% |
| Sep 30, 2022 | 3.01% |
| Jun 30, 2022 | -3.61% |
| Dec 31, 2021 | -217.91% |
| Sep 30, 2021 | -132.86% |
| Jun 30, 2021 | -129.45% |
| Sep 30, 2020 | 29.72% |
| Jun 30, 2020 | 21.22% |
| Sep 30, 2019 | -47.65% |